Development of PSMA ligands for the diagnosis and therapy of prostate cancer (Q3313535)

From EU Knowledge Graph
Jump to navigation Jump to search
Project Q3313535 in Germany
Language Label Description Also known as
English
Development of PSMA ligands for the diagnosis and therapy of prostate cancer
Project Q3313535 in Germany

    Statements

    0 references
    1,019,386.0 Euro
    0 references
    1,274,232.5 Euro
    0 references
    80.0 percent
    0 references
    2 January 2019
    0 references
    31 December 2021
    0 references
    ABX advanced biochemicalcompounds-BiomedizinischeForschungsreagenzien GmbH
    0 references
    0 references
    0 references

    51°6'54.50"N, 13°55'3.11"E
    0 references
    Entwicklung von PSMA-Liganden für die Diagnostik und Therapie des Prostatakarzinoms (German)
    0 references
    Development of PSMA ligands for the diagnosis and therapy of prostate cancer (English)
    25 October 2021
    0.0073943229522744
    0 references
    Développement de ligands PSMA pour le diagnostic et le traitement du cancer de la prostate (French)
    6 December 2021
    0 references
    Ontwikkeling van PSMA liganden voor de diagnose en therapie van prostaatkanker (Dutch)
    19 December 2021
    0 references
    Sviluppo di leganti PSMA per la diagnosi e la terapia del cancro alla prostata (Italian)
    19 January 2022
    0 references
    Desarrollo de ligandos PSMA para el diagnóstico y terapia del cáncer de próstata (Spanish)
    22 January 2022
    0 references
    Ανάπτυξη συνδέσμων PSMA για τη διάγνωση και θεραπεία του καρκίνου του προστάτη (Greek)
    19 August 2022
    0 references
    Udvikling af PSMA ligander til diagnosticering og behandling af prostatakræft (Danish)
    19 August 2022
    0 references
    PSMA-ligandien kehittäminen eturauhassyövän diagnosointiin ja hoitoon (Finnish)
    19 August 2022
    0 references
    Żvilupp ta’ ligandi PSMA għad-dijanjosi u t-terapija tal-kanċer tal-prostata (Maltese)
    19 August 2022
    0 references
    PSMA ligandu izstrāde prostatas vēža diagnostikai un terapijai (Latvian)
    19 August 2022
    0 references
    Vývoj PSMA ligandov pre diagnostiku a terapiu rakoviny prostaty (Slovak)
    19 August 2022
    0 references
    Forbairt ligands PSMA le haghaidh diagnóis agus teiripe ailse próstatach (Irish)
    19 August 2022
    0 references
    Vývoj PSMA ligandů pro diagnostiku a léčbu rakoviny prostaty (Czech)
    19 August 2022
    0 references
    Desenvolvimento de ligantes PSMA para o diagnóstico e terapia do cancro da próstata (Portuguese)
    19 August 2022
    0 references
    PSMA ligandite väljatöötamine eesnäärmevähi diagnoosimiseks ja raviks (Estonian)
    19 August 2022
    0 references
    PSMA ligandumok fejlesztése a prosztatarák diagnosztizálására és kezelésére (Hungarian)
    19 August 2022
    0 references
    Развитие на PSMA лиганди за диагностика и лечение на рак на простатата (Bulgarian)
    19 August 2022
    0 references
    PSMA ligandų kūrimas prostatos vėžio diagnozei ir gydymui (Lithuanian)
    19 August 2022
    0 references
    Razvoj PSMA liganda za dijagnozu i terapiju raka prostate (Croatian)
    19 August 2022
    0 references
    Utveckling av PSMA ligands för diagnos och behandling av prostatacancer (Swedish)
    19 August 2022
    0 references
    Dezvoltarea liganzilor PSMA pentru diagnosticul și terapia cancerului de prostată (Romanian)
    19 August 2022
    0 references
    Razvoj ligandov PSMA za diagnosticiranje in zdravljenje raka prostate (Slovenian)
    19 August 2022
    0 references
    Rozwój ligandów PSMA w diagnostyce i leczeniu raka prostaty (Polish)
    19 August 2022
    0 references
    Radeberg, Stadt
    0 references

    Identifiers

    672 / 101003636511
    0 references